EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and antitumor activity of matrine aminophosphonate derivatives as potent mcl-1 inhibitors

Xiaoqun Zhou, Mingjun Zhu, Caina Jiang, Xianli Ma, Fangyao Li

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2025.109449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Xiaoqun Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggabilit…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Myeloid Cell Leukemia Sequence 1 Protein, Drug Design, Quinolizines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Guangxi Natural Science Foundation, Science and Technology Major Project of Guangxi, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of novel matrine aminophosphonate derivatives were designed and synthesized to explore more efficacious and less toxic Mcl-1 inhibitors, following the principle of combination and hybridization. The representative compound, 9 k, exhibited more potent cytotoxicity against human cervical cancer cells compared to the positive control 5-FU. A molecular docking study was also conducted to understand the interactions of 9 k with the Mcl-1 protein. Mechanistic studies revealed that compound 9 k could induce apoptosis in Hela cells, accompanied by changes in chromatin morphology, an elevation of intracellular ROS levels, and the dissipation of MMP. Notably, in vivo studies indicated that 9 k inhibited tumor growth in a Hela xenograft model. In summary, this study suggests that compound 9 k represents a potent and selective Mcl-1 inhibitor for the treatment of human cervical cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsMyeloid Cell Leukemia Sequence 1 ProteinDrug DesignQuinolizinesAlkaloidsOrganophosphonatesHumansMatrinesStructure-Activity RelationshipDrug Screening Assays, AntitumorCell ProliferationAnimalsApoptosisMolecular Docking SimulationMolecular StructureHeLa CellsDose-Response Relationship, DrugFemaleMice

Stichwörter der Autor:innen

AminophosphonateCell apoptosisMatrineMcl-1 inhibitors

Substanzen

Antineoplastic AgentsMatrinesMyeloid Cell Leukemia Sequence 1 ProteinQuinolizinesAlkaloidsOrganophosphonatesMCL1 protein, human

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Drug Discovery and Optimization, Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, Key Laboratory of Medical Biotechnology and Translationa…

Förderung

  • Guangxi Natural Science Foundation
  • Science and Technology Major Project of Guangxi
  • National Natural Science Foundation of China
  • Guilin Medical University

Zitieren

APA

Zhou, X., Zhu, M., Jiang, C., Ma, X., & Li, F. (2026). Design, synthesis, and antitumor activity of matrine aminophosphonate derivatives as potent mcl-1 inhibitors. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.109449

Vancouver

Zhou X, Zhu M, Jiang C, Ma X, Li F. Design, synthesis, and antitumor activity of matrine aminophosphonate derivatives as potent mcl-1 inhibitors. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2025.109449

BibTeX
@article{Zhou2026,
  author = {Zhou, Xiaoqun and Zhu, Mingjun and Jiang, Caina and Ma, Xianli and Li, Fangyao},
  title = {Design, synthesis, and antitumor activity of matrine aminophosphonate derivatives as potent mcl-1 inhibitors},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2025.109449}
}
Kostenlos starten →